EQUILLIUM, INC. Additional Paid in Capital, Common Stock
EQUILLIUM, INC. (EQ) had Additional Paid in Capital, Common Stock of $281.84 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-13
- 2026-06-30: Additional Paid in Capital, Common Stock $281.84M.
- 2026-03-31: Additional Paid in Capital, Common Stock $280.63M.
- 2025-12-31: Additional Paid in Capital, Common Stock $244.43M.
- 2025-09-30: Additional Paid in Capital, Common Stock $243.09M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $281.84M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $280.63M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $244.43M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $243.09M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $212.87M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $212.31M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $212.08M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $211.19M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $210.19M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $209.14M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $208.17M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $207.04M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $206.33M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $205.31M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $204.27M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $203.14M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $201.94M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $200.47M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $176.62M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $175.22M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $174.05M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $172.05M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $141.07M 10-K · filed 2022-03-23 | |
| 2020-09-30 | $140.16M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $86.28M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $84.82M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $82.94M 10-K · filed 2021-03-24 | |
| 2019-09-30 | $82.42M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $81.51M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $80.91M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $80.44M 10-K · filed 2020-03-26 | $80.44M 10-K · filed 2019-03-27 |
| 2018-09-30 | $141.53K 10-Q · filed 2018-11-15 | |
| 2017-12-31 | $9.66K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |